Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Heart Transplant Market Through 2034?
The market size for heart transplants has seen significant growth in the past few years. The size is estimated to expand from $11.49 billion in 2024 to $12.62 billion in 2025, witnessing a compound annual growth rate (CAGR) of 9.9%. Factors contributing to growth during the historic period include advancements in medical technology, enhanced awareness and education, developments in organ preservation methods, and improvements in healthcare infrastructure.
The market for heart transplants is predicted to experience significant expansion in the near future. The estimated market size is due to reach $18.14 billion in 2029 with a compound annual growth rate of 9.5%. The anticipated surge over the forecast period is largely due to factors such as government backing and funding, global expansion of transplant programs, augmentation of transplant center capacity, and inclusion of telemedicine and remote monitoring. Technological progress, artificial heart and aid devices, and the use of artificial intelligence in donor organ selection will be the major trends within the forecast period.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Heart Transplant Market?
The increasing presence of heart conditions is anticipated to stimulate growth in the heart transplantation market. These cardiovascular diseases encompass various conditions impacting the heart and blood vessels. A heart transplant procedure is oftentimes the final treatment option for patients with advanced heart failure who have seen no improvement with other treatments. Such a procedure can enhance quality of life and prolong life expectancy. For instance, per the British Heart Foundation, a charity based in the UK that focuses on cardiovascular research, approximately 7.6 million people in the UK, consisting of 4 million men and 3.6 million women, are presently dealing with heart and circulatory diseases. Projections indicate that this number could ascend by 1 million by 2030, and potentially see an increase of an additional 2 million by 2040 compared to the current figures. As such, the widespread nature of cardiovascular diseases is expected to fuel the heart transplant market.
Which Key Market Segments Comprise the Heart Transplant Market and Drive Its Revenue Growth?
The heart transplantmarket covered in this report is segmented –
1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types
2) By Transplant: Autograft; Allograft; Other Transplants
3) By End-User: Hospitals; Cardiac Institutes; Other End-Users
Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart
2) By Biventricular Pacing: Cardiac Resynchronization Therapy Pacemakers (CRT-P); Cardiac Resynchronization Therapy Defibrillators (CRT-D)
3) By Ventricular Assist Devices: Left Ventricular Assist Device (LVAD); Right Ventricular Assist Device (RVAD); Biventricular Assist Device (BIVAD)
4) By Other Surgery Types: Heart And Lung Transplant; Heterotopic Heart Transplant
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12967&type=smp
Which Areas Are Leading Regions in the Heart Transplant Market Expansion Across the Globe?
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Strategic Trends Steering theHeart Transplant Market Direction?
Key players in the heart transplant market, including companies like Xvivo Perfusion AB, are increasingly turning their attention towards fostering innovative solutions such as heart preservation technology. This technology aims to extend the preservation life of a heart outside the body compared to traditional ice storage methods. As a result, it promotes improved post-transplant conditions and fewer complications. In May 2023, Xvivo Perfusion, a medical technology firm based in Sweden, obtained the green light from the U.S. Food and Drug Administration for an Investigational Device Exemption (IDE) for its unique heart preservation technology. This approval ultimately kick-started the ‘PRESERVE Clinical Trial.’ The trial is a single-arm, open-label, prospective study angled towards assessing hearts transplanted from extended donors after employing non-ischemic heart preservation methods. This method includes Donation after Circulatory Death (DCD) hearts. One distinctive aspect of XVIVO’s heart preservation approach is its hypothermic perfusion system that is non-ischemic, using cold, oxygenated perfusion to preserve donor hearts during transit.
View the full report here:
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report
How Is the Heart Transplant Market Conceptually Defined?
A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12967
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model